We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Testing Personalized Treatments in 5 Days With 3D

News   May 22, 2019 | Original story from University of Geneva (UNIGE)

 
Testing Personalized Treatments in 5 Days With 3D

Representative image of 3D model of colorectal carcinoma (HCT116 cells) exposed for 72 hours to treatment with a three-drug combination containing regorafenib, erlotinib and 5-fluorouracil. The cell-tracker stained cells correspond to cell nuclei (blue), live cells (green) and dead cells (red). © UNIGE, Molecular Pharmacology Group

 
 
 

RELATED ARTICLES

Daily Exposure to Blue Light May Accelerate Aging

News

New research using fruit flies suggests that blue light could damage cells and may accelerate aging.

READ MORE

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE